Our Recommendations
New Publications
- Filariasis linfática - Datos y cifras (2022)
- Lymphatic filariasis - Key facts (2022)
- Лимфатический филяриоз - Основные факты (2022)
- Filariose lymphatique - Principaux faits (2022)
- Development and Introduction of the Filariasis Test Strip: A New Diagnostic Test for the Global Program to Eliminate Lymphatic Filariasis (2022)
Filter
50
Featured
Language
Document type
Studies & Reports
25
Manuals
6
Videos
6
Guidelines
5
Strategic & Response Plan
4
Infographics
2
Training Material
1
Fact sheets
1
Countries / Regions
Global
22
Africa
2
Latin America and the Carribbean
2
Ghana
1
Saudi Arabia
1
Western Pacific Region
1
Djibouti
1
Egypt
1
Sudan
1
Yemen
1
Zambia
1
Somalia
1
India
1
Authors & Publishers
Publication Years
Category
Lymphaticfilariasis
5
Countries
4
Trachoma
2
Leprosy
2
Chagas
1
Studies & Reports
1
NTDs & Others
1
Toolboxes
Studies & Reports
14
Capacity Building & Resources
9
Prevention & Control
9
Clinical Aspects & Diagnostics
8
Information & Education Material (IEC)
7
Statistics & Facts
7
We are pleased to provide an editorial to introduce this series of articles on the achievements of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) over the last 2 decades. We
are delighted that so many of the major players in this journey have agreed to contribute to this supplement,...
Many countries have made significant progress in the implementation of World Health Organization recommended preventive chemotherapy strategy, to eliminate lymphatic filariasis (LF). However, pertinent challenges such as the existence of areas of residual infections in disease endemic districts pose...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
Lymphatic filariasis (LF) is a preventable neglected tropical disease (NTD) caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi or B. timori. Mosquitos in the genera Culex, Anopheles, Mansonia and Aedes transmit the parasites from person to person. Lymphoedema and hyd...
The document explains why vector control is important in national programmes and describes the preparation of a tailor-made vector control plan for national programmes. It outlines entomological procedures for regular and specific vector control and how data should be analysed for better overall und...
Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme managers, second edition: web annex A: protocol for evaluating minimum package of care of morbidity management and disability prevention for lymphoedema management in designated health facilit...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
